| Cat. No. |
Product Name |
Information |
| PC-26711 |
BLU0588
PRKACA inhibitor
|
BLU0588 is a potent, selective and orally acitve protein kinase A (PKA) alpha catalytic subunit (PRKACA) inhibitor with IC50 of 1 nM and Kd of 4 nM. |
| PC-26712 |
BLU2864
PRKACA inhibitor
|
BLU2864 is a potent, selective and orally acitve protein kinase A (PKA) alpha catalytic subunit (PRKACA) inhibitor with IC50 of 0.3 nM and Kd of 3.3 nM. |
| PC-23453 |
KT5720
PKA inhibitor
|
KT5720 is a potent, cell-permeable, specific, reversible and ATP-competitive PKA inhibitor with IC50 of 3.3 uM. |
| PC-23452 |
PKI 14-22 amide, myristoylated
PKA inhibitor
|
PKI 14-22 amide,myristoylated is a potent cAMP-dependent PKA inhibitor. PKI 14-22 amide,myristoylated reduces the IgG-mediated phagocytic response and also inhibits neutrophil adhesion |
| PC-22434 |
CW008
PKA modulator
|
CW008 is a small molecule activator of the cAMP/PKA/CREB pathway, stimulates osteoblast differentiation of human mesenchymal stem cells (MSCs) and increases bone formation. |
| PC-42077 |
Synaptamide
|
An endogenous DHA metabolite that promotes neurite growth, synaptogenesis, and synaptic function both in vitro and in vivo. |